Back
Reviva Pharmaceuticals Holdings Stock Price Chart
Sell
14
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.72
Seasonality Move:
-41.26%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVPH is experiencing slight buying pressure.
Reviva Pharmaceuticals Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Sell |
| 20-day SMA: | 2.66 | Sell |
| 50-day SMA: | 3.09 | Sell |
| 200-day SMA: | 4.09 | Sell |
| 8-day EMA: | 2.05 | Sell |
| 20-day EMA: | 2.53 | Sell |
| 50-day EMA: | 3.04 | Sell |
| 200-day EMA: | 3.9 | Sell |
Reviva Pharmaceuticals Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 23.5 | Sell |
| Chaikin Money Flow: | 67322 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.22 - 3.38) | Sell |
| Bollinger Bands (100): | (2.89 - 4.49) | Sell |
Reviva Pharmaceuticals Holdings Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reviva Pharmaceuticals Holdings Stock
Is Reviva Pharmaceuticals Holdings Stock a Buy?
- Reviva Pharmaceuticals Holdings share price is 1.71 while RVPH 8-day simple moving average is 2.07, which is a Sell signal.
- The stock price of RVPH is 1.71 while Reviva Pharmaceuticals Holdings 20-day SMA is 2.66, which makes it a Sell.
- Reviva Pharmaceuticals Holdings 50-day simple moving average is 3.09 while RVPH share price is 1.71, making it a Sell technically.
- RVPH stock price is 1.71 and Reviva Pharmaceuticals Holdings 200-day simple moving average is 4.09, creating a Sell signal.
RVPH Technical Analysis vs Fundamental Analysis
Sell
14
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Is Reviva Pharmaceuticals Holdings a Buy or a Sell?
-
Reviva Pharmaceuticals Holdings stock is rated a Sell
The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.71. The Score for RVPH is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Reviva Pharmaceuticals Holdings Stock Info
Market Cap:
47.74M
Price in USD:
1.71
Share Volume:
157.09K
Reviva Pharmaceuticals Holdings 52-Week Range
52-Week High:
8.30
52-Week Low:
1.60
Sell
14
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Reviva Pharmaceuticals Holdings Share Price Forecast
-
What is the Reviva Pharmaceuticals Holdings stock price today?
The Reviva Pharmaceuticals Holdings stock price is 1.71 USD today. -
Will RVPH stock go up or go down?
Reviva Pharmaceuticals Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Reviva Pharmaceuticals Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reviva Pharmaceuticals Holdings is overvalued.
Is Reviva Pharmaceuticals Holdings Stock a Buy?
- Reviva Pharmaceuticals Holdings share price is 1.71 while RVPH 8-day exponential moving average is 2.05, which is a Sell signal.
- The stock price of RVPH is 1.71 while Reviva Pharmaceuticals Holdings 20-day EMA is 2.53, which makes it a Sell.
- Reviva Pharmaceuticals Holdings 50-day exponential moving average is 3.04 while RVPH share price is 1.71, making it a Sell technically.
- RVPH stock price is 1.71 and Reviva Pharmaceuticals Holdings 200-day simple moving average is 3.90, creating a Sell signal.
Fundamental Analysis of Reviva Pharmaceuticals Holdings
Is Reviva Pharmaceuticals Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.27 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Reviva Pharmaceuticals Holdings
Should I short Reviva Pharmaceuticals Holdings stock?
- RVPH Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Reviva Pharmaceuticals Holdings is a Sell
- Reviva Pharmaceuticals Holdings Relative Strength Index (RSI) is 23.5, which suggest Reviva Pharmaceuticals Holdings is oversold
- The Bollinger Bands (25) for Reviva Pharmaceuticals Holdings is (2.22 - 3.38), which suggest Reviva Pharmaceuticals Holdings is a Sell
- The Bollinger Bands (100) for Reviva Pharmaceuticals Holdings is (2.89 - 4.49), which suggest Reviva Pharmaceuticals Holdings is a Sell
* Reviva Pharmaceuticals Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.